Skip to content

Missed Urology Referral After an Abnormal PSA: Your Rights in New York

A high PSA number on a lab report does not tell you much by itself. What matters is what your doctor does next. In a well-run practice, an elevated PSA or an abnormal prostate exam leads to a conversation with the patient, a referral to a urologist, and a system that tracks whether the visit actually happens. In many of the cases we see, that chain breaks somewhere in the middle.

The result sits in the chart. The referral is "recommended" but never sent. The patient learns nothing was done until a biopsy a year or two later shows cancer that has spread beyond the prostate.

If that sounds like what happened to you or someone in your family, you are probably asking two questions: did the delay actually change anything, and can a lawyer help? Here is what to know.

Should Your Cancer Have Been Found Sooner?

Contact us today for a free consultation.

What Counts as an Abnormal PSA or Exam?

There is no single number that separates "fine" from "needs a urologist." PSA is read alongside a digital rectal exam, and a good doctor looks at the whole picture.

A PSA above 4.0 ng/mL has long been treated as a level that calls for further evaluation, though urologists increasingly describe risk as a continuum rather than a hard cutoff. A few other measures matter as much as the number itself:

  • PSA velocity, how quickly the level has risen from one test to the next

  • PSA density, the level compared with the size of the prostate

  • The trend, because a borderline number can look very different next to results from a year or two earlier

PSA can also rise for reasons other than cancer, including an enlarged prostate or inflammation, which is why an elevated result calls for evaluation rather than a diagnosis.

The physical exam carries real weight too. A nodule, hard area, or asymmetry found on a rectal exam is enough on its own to justify a urology referral, even when the PSA looks unremarkable. Many men assume a normal PSA means there is nothing to worry about, but an abnormal exam with a normal PSA is still a finding that has to be acted on.

Screening Guidelines and Why They Matter

Screening guidance has shifted over the years, and knowing what it says helps show whether a missed diagnosis was foreseeable.

The American Cancer Society recommends that men discuss screening with their doctor starting at:

  • Age 50 for men at average risk who are expected to live at least 10 more years

  • Age 45 for Black men and men whose father or brother was diagnosed before age 65

  • Age 40 for men with more than one first-degree relative diagnosed at an early age

For men who are screened, ACS suggests retesting every two years when PSA is below 2.5 ng/mL and every year when it is 2.5 or higher. Our prostate cancer screening protocols page covers these guidelines in more detail.

The U.S. Preventive Services Task Force takes a narrower view. Its 2018 recommendation calls screening an individual decision for men 55 to 69 and advises against routine screening at 70 and older. The Task Force has noted that an update is in progress.

The guidelines matter less than you might think in a missed-referral case. Once a PSA test has been ordered and comes back abnormal, the screening debate is over. The question is no longer whether to test, but what to do about a result already sitting in the chart.

What Is Supposed to Happen After an Abnormal Result?

There is a well-established sequence after an abnormal PSA or exam, and knowing it shows exactly where things tend to break down:

  1. The patient is told. The doctor who ordered the test is responsible for making sure the patient knows about the result. A number posted to a patient portal that nobody explains is not the same as telling a patient something needs attention.

  2. The referral is actually made. If urology is warranted, there should be a referral order, not just a note that a referral was "discussed" or "recommended."

  3. Someone tracks it. A well-run practice checks whether the patient made it to the urologist and reaches back out if he did not.

  4. The urologist works it up. The usual next steps include a repeat PSA, often an MRI, and possibly a biopsy.

  5. The findings are acted on. Whatever the workup shows has to be communicated and followed up, and the same responsibility applies again.

How Often Does the Follow-Up Fall Through?

More often than most patients would guess. A 2023 study from Albert Einstein College of Medicine followed 1,335 men aged 50 and older in a diverse, urban health network affiliated with the Bronx medical school who were referred to urology for an elevated PSA between 2018 and 2021. Only 44 percent saw a urologist within four months. Another 16 percent were seen later, after a median of 210 days. The remaining 40 percent never had a urology evaluation at all. The authors called for safeguards such as patient navigation to make sure referrals are completed.

An earlier study of 46 primary care practices looked at men whose PSA reached 10.0 ng/mL or higher for the first time, a result well past any borderline range. Even then, follow-up took an average of more than three months.

The reasons repeat themselves from case to case:

  • The result was never explained to the patient in a way he understood

  • The referral was never formally entered or sent

  • Nobody tracked which referrals were still open

  • The patient hit insurance or scheduling barriers and no one at the practice helped

Does a Delayed Diagnosis Change the Outcome?

This is usually the real question, and the honest answer is that it depends on stage.

According to SEER data, prostate cancer that is still confined to the prostate, or has reached only nearby lymph nodes, has a five-year relative survival rate near 100 percent. Once it spreads to distant parts of the body, such as bone, five-year survival drops to about 40 percent. Earlier treatment also tends to mean more options and less aggressive therapy.

That gap is why the timing of a referral matters so much. A cancer that could have been treated with surgery or radiation while still localized can become a cancer in the bones by the time someone finally orders the biopsy that should have happened a year or two earlier.

Prostate cancer is the most commonly diagnosed cancer in American men, with about 333,830 new cases projected for 2026. SEER data show Black men are diagnosed at a rate about 64 percent higher than white men and die of the disease at about twice the rate. When a referral is delayed for a man who was already at higher risk, the stakes are higher too.

Can You Sue for a Missed Urology Referral in New York?

Yes, if the delay caused real harm. New York law does not require you to prove that a timely referral would have guaranteed a cure. A claim generally has to establish:

  • A departure from accepted practice, such as failing to tell the patient about an abnormal PSA, never sending a referral, or never following up on one

  • Causation, meaning the departure was a substantial factor in the harm

  • Damages that resulted

New York courts have also allowed claims where the evidence showed a delay meaningfully reduced the patient's chance of a better outcome, even when that chance was not high to begin with. In prostate cancer cases, the central issue is almost always staging: what stage the cancer was in when the referral should have happened, compared with the stage it had reached when it was finally caught.

Proving that usually takes a urologist or urologic oncologist who reviews the records and explains what should have happened, when, and what the delay cost.

How Long Do You Have to File a Claim?

New York's deadlines are strict, and several rules can apply to the same case.

The general rule. Under CPLR 214-a, a malpractice lawsuit generally must be filed within two years and six months of the act or omission.

Continuous treatment. If you kept seeing the same doctor or practice for the same condition, the clock may not start until that treatment ends. This comes up often in PSA cases, because a man may keep seeing the same primary care doctor for years after an abnormal result was quietly dropped.

Lavern's Law. For a claim based on a failure to diagnose cancer, a 2018 amendment lets the two-and-a-half-year period run from the later of two dates: when you knew or reasonably should have known of the negligent act and the harm it caused, or your last continuous treatment. The discovery rule has an outer limit of seven years from the negligent act. This matters in PSA cases, where men often learn about an old, unreferred result only when a new doctor pulls their records after a late-stage diagnosis.

Public hospitals and clinics. If the missed referral happened at a facility run by a public entity, such as NYC Health + Hospitals or a county hospital, a much shorter deadline applies. Under General Municipal Law § 50-e, a formal notice of claim generally must be served within 90 days. A court can allow late notice in some situations, but that is not guaranteed. The lawsuit itself typically must follow within one year and 90 days under § 50-i. State-run hospitals follow separate Court of Claims rules.

Because these deadlines can overlap, talk to an attorney as soon as you suspect something was missed.

What Records Prove These Cases?

Missed-referral cases are won or lost on paper. Under Public Health Law § 18, you have the right to copies of your medical records, and paper copies cannot cost more than 75 cents a page. The proof is often in the doctor's own notes.

The records that tend to matter most:

  • The abnormal PSA result or exam finding, and the date it came in

  • Any referral order, or a note that a referral was "recommended" with nothing sent

  • Portal messages and after-visit summaries showing what you were told

  • Referral logs or scheduling records showing whether anyone followed up

  • Later visits where the abnormal result was never mentioned again

Sometimes the records show a referral was made, but nobody followed up when the patient never went. Either way, they show whether the practice had any real system for closing the loop or left the result to chance. You can learn more about how prostate cancer is caught early on our prostate cancer early detection page.

Talk With a New York Cancer Lawyer

An elevated PSA or an abnormal prostate exam is supposed to set a clear chain of events in motion: tell the patient, make the referral, confirm it happens, and act on what the urologist finds. When that chain breaks and the cancer is caught at a later stage, New York law allows patients and families to hold the responsible providers accountable.

Porter Law Group's prostate cancer malpractice lawyers work with board-certified medical experts to review these timelines, and you can see our results in delayed cancer diagnosis cases. Call 833-888-LATE or request a free case evaluation.

Attorney advertising. This article provides general information and is not legal or medical advice. Prior results do not guarantee a similar outcome. Filing deadlines depend on the facts of each case.

Frequently Asked Questions

What PSA level should lead to a urology referral?

There is no single cutoff. A PSA above 4.0 ng/mL has long been treated as a level that calls for further evaluation, but doctors should also weigh how fast PSA is rising, prostate size, and the rectal exam. An abnormal rectal exam can justify a referral even when PSA looks normal.

Can I sue my doctor for not referring me to a urologist after a high PSA?

You may be able to if the doctor failed to tell you about the result, never sent the referral, or never followed up, and the delay let the cancer progress. You do not have to prove a timely referral would have guaranteed a cure. A urology expert usually has to review your records.

How common are missed referrals after an abnormal PSA?

More common than most men expect. In a 2023 study of 1,335 men referred to urology for an elevated PSA, 40 percent never saw a urologist, and another 16 percent waited a median of about seven months. Missed communication, unsent referrals, and no tracking system are frequent causes.

How long do I have to file a missed prostate cancer claim in New York?

The general malpractice deadline is two years and six months. For a missed cancer diagnosis, Lavern's Law lets that period run from when you knew or should have known of the mistake and the harm it caused, with a seven-year outer limit. Claims against public hospitals require a notice of claim within 90 days.

What records should I get to prove a missed urology referral?

Request your complete chart, including PSA results, exam notes, referral orders, portal messages, after-visit summaries, and scheduling records. New York Public Health Law § 18 gives you the right to copies, at no more than 75 cents per paper page. These records often show whether a referral was ever actually sent.

Free case evaluation

Talk With a New York Cancer Lawyer

If a delayed diagnosis changed your family's future, Porter Law Group can review what happened and explain your options.